IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 138 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $301,000 | -3.5% | 19,662 | 0.0% | 0.09% | +3.6% |
| Q3 2016 | $312,000 | +21.4% | 19,662 | 0.0% | 0.08% | +31.2% |
| Q2 2016 | $257,000 | +19.5% | 19,662 | 0.0% | 0.06% | +18.5% |
| Q1 2016 | $215,000 | -5.7% | 19,662 | 0.0% | 0.05% | -1.8% |
| Q4 2015 | $228,000 | +11.2% | 19,662 | 0.0% | 0.06% | -5.2% |
| Q3 2015 | $205,000 | -13.5% | 19,662 | 0.0% | 0.06% | -12.1% |
| Q2 2015 | $237,000 | -24.8% | 19,662 | 0.0% | 0.07% | -20.5% |
| Q1 2015 | $315,000 | +4.7% | 19,662 | 0.0% | 0.08% | +6.4% |
| Q4 2014 | $301,000 | +18.0% | 19,662 | 0.0% | 0.08% | +2.6% |
| Q3 2014 | $255,000 | -15.3% | 19,662 | 0.0% | 0.08% | -8.4% |
| Q2 2014 | $301,000 | +24.4% | 19,662 | 0.0% | 0.08% | +18.6% |
| Q1 2014 | $242,000 | +6.1% | 19,662 | 0.0% | 0.07% | +2.9% |
| Q4 2013 | $228,000 | -2.1% | 19,662 | 0.0% | 0.07% | -6.8% |
| Q3 2013 | $233,000 | +19.5% | 19,662 | 0.0% | 0.07% | +23.7% |
| Q2 2013 | $195,000 | – | 19,662 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |